Where does Next Paradigm Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Next Paradigm Inc. ranks #49,066 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Next Paradigm Inc. hold?

Next Paradigm Inc. holds 5 US utility patents granted between 2016 and 2017, spanning 2 technology areas.

What is Next Paradigm Inc.'s Innovation Score?

Next Paradigm Inc. has an Innovation Score of 18.5 out of 100 (5th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Next Paradigm Inc.'s patent grant rate increasing or decreasing?

Next Paradigm Inc.'s recent grant velocity is -100% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Next Paradigm Inc.'s patents?

Next Paradigm Inc.'s patents average 12.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Next Paradigm Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Next Paradigm Inc.

Q: What technology areas does Next Paradigm Inc. focus on?

Next Paradigm Inc.'s top technology area is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle) with 5 patents, ranking #204 of 903 assignees active in that subclass. Grants appear in 2 CPC subclasses total.

USPTO PatentsView assignee record - 5 granted patents across 2 technology areas, recorded in grant years 2016–2017. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Next ranks #49,066 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 2 technology areas.

#49,066
of 49,997 US assignees by volume: 5th percentile
by Innovation Score (18.5/100): 12.2
avg claims per patent: -100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R49066 · Foreign Corporation #49,066 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #49,066/49,997
PHOTO-FINISH Nexagen
CPC-NARROW A61J · 2 areas
INNOV-LOW 18.5/100
CLAIMS-RICH 12.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -100% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nexagen Corp. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Next’s 18.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (34%) Velocity 0.0 pts (0%) Breadth 5.0 pts (27%) Claim depth 7.3 pts (39%)

Qualcomm Incorporated · highest

85
Next Paradigm · this assignee

19
3D Lighting… · lowest

7

What this shows Next's Innovation Score is 18.5/100 (5th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Next?

Each dot is one of Next’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Next’s own 12.2 claims/patent is at or below the 16.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Next vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Next's grants concentrate

Next Paradigm Inc. is a focused PatentsView assignee: 2 CPC subclasses with 100% of grants classified under A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ). Peak complete grant year is 2017 (3 grants) versus a trough of 2 in 2016. By volume, Next sits between NexGen Oil Tools Inc. and Nextplane, Inc..

Nexgen Oil Tools

5
Nextech AR Soluti…

5
Nexagen

5
Nexe Innovations

5
Next2me

5
Nextgin Technolog…

5
Nextbio

5
Nextplane

5
Next Paradigm ◀

5

What this shows Next holds 5 patents at rank #49,167, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Next

By rank, the assignees closest to #49,167 in granted patent volume.

Leaders in A61J (Containers Specially Adapted FOR Medical OR Pharmaceutica…)

Other assignees with the most granted patents in Next's primary technology class.

Next's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

19 5th percentile higher than 5% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2017

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Next Paradigm Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	2	40.0%
2017	3	60.0%

Which technologies does Next Paradigm Inc. patent most?

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 5

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 4

Top 2 of 2 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Next Paradigm Inc.'s patent record in context - here's where to go next.

Next Paradigm Inc.'s lead technology class is A61J (Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices ), 100% of its portfolio - see every assignee active in that class. Explore A61J
Ranked #49,066 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Next Paradigm Inc. against NexGen Oil Tools Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 18.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.